chromoblastomycosis

chromoblastomycosis is a chronic fungal infection of the skin and subcutaneous tissue.

diagnosis of chromoblastomycosis is confirmed by observing muriform cells in tissue samples.

the primary treatment for chromoblastomycosis often involves prolonged systemic antifungal therapy.

prolonged exposure to soil and decaying vegetation is a major risk factor for chromoblastomycosis.

itraconazole is frequently prescribed to manage mild to moderate cases of chromoblastomycosis.

pathologists identify chromoblastomycosis by detecting dark-pigmented sclerotic bodies in biopsy specimens.

without proper medical intervention, chromoblastomycosis can cause severe tissue fibrosis and disability.

fonsecaea pedrosoi is the most common etiologic agent of chromoblastomycosis worldwide.

cryosurgery is sometimes combined with drug therapy to treat refractory chromoblastomycosis lesions.

common clinical presentations of chromoblastomycosis include verrucous nodules and scaly plaques.

recognizing chromoblastomycosis early is crucial to preventing the need for extensive surgery.

doctors differentiate chromoblastomycosis from cutaneous tuberculosis through laboratory culture and histopathology.